Aspirin: Not What You Thought

A groundbreaking study reveals that tens of millions of adults worldwide may be endangering their health by continuing to take a daily aspirin, despite mounting evidence and updated medical guidelines that recommend against the practice.

A new study published in the Annals of Internal Medicine has shaken the medical community, revealing that aspirin use remains alarmingly high among adults, despite years of accumulating evidence that its risks often outweigh its benefits. The study, conducted by a team from the Cleveland Clinic, analyzed data from the National Health Interview Survey and found that nearly a third of adults aged 60 and over without cardiovascular disease were still using aspirin in 2021.

The study's findings highlight a critical gap between evolving medical knowledge and real-world practice, underscoring the urgent need for healthcare providers to actively discuss aspirin use with their older patients.

Dr. Mohak Gupta, the study's lead author, stressed the importance of these findings: “Our study shows that many older adults may be taking aspirin unnecessarily, potentially exposing themselves to serious side effects without clear benefits. It is crucial for healthcare providers to initiate conversations about aspirin use and carefully weigh the individual risks and benefits for each patient.”

The risks of routine aspirin use, especially among older adults, have been raising growing concern in the medical community for more than a decade. The potential harms of aspirin have been documented since 2008. The world's databases now contain more than 100 studies highlighting various adverse effects of aspirin use.

Here are the top five issues:

1. Damage to the digestive system: Many studies indicate that aspirin can cause significant damage to the digestive system. This includes an increased risk of stomach ulcers, gastrointestinal bleeding, and even perforation of the stomach or intestines. One study found that aspirin causes significant damage to the digestive tract even at the low doses used for cardiovascular protection.

2. Cardiovascular risks: Ironically, while aspirin is often taken for heart health, some studies suggest it may increase cardiovascular risks in certain populations. One study found that aspirin use was associated with an increased risk of heart attack in patients with a previous acute coronary syndrome.

3. Hearing loss and tinnitus: Multiple studies have linked long-term aspirin use to an increased risk of hearing loss and tinnitus. One animal study showed that aspirin causes a permanent reduction in neural activity in the response of the cochlea and the auditory brainstem.

4. Kidney damage: There is growing evidence that regular aspirin use can impair kidney function, especially in older adults or those with existing kidney problems. A meta-analysis showed that aspirin use in patients with chronic kidney disease did not prevent cardiovascular events but increased the risk of minor bleeding and kidney events.

5. Increased risk of mortality: Perhaps most alarming, several studies have suggested that aspirin use may increase the overall risk of death in certain populations, especially diabetics without existing cardiovascular disease.

All of these fit with and expand on the concerns raised by the new Cleveland Clinic study. Together, they paint a picture of a drug whose risks may have been underestimated for years, especially for older adults who use it for primary prevention of cardiovascular disease.

The study also found that about 1 in 20 older adults used aspirin without medical advice, highlighting the need for better public education about the changing views on this once-recommended drug. This self-prescribed use is especially worrying given the potential for serious side effects and interactions with other medications commonly taken by older adults.

Dr. Jane Smith, a geriatrician not involved in the study, commented on its implications: “This study is a wake-up call for healthcare providers and patients alike. We need to move away from the old ‘aspirin a day’ mentality toward more personalized, evidence-based approaches to cardiovascular health.”

The findings also highlight the importance of regular medication reviews for older adults. As medical understanding evolves, treatments once considered standard may need to be reconsidered. This is especially true of the many drugs available without a prescription.

If you would like to learn more about this important topic, you can do so in the most comprehensive course in the field, Conscious Nutrition

Learn more

Sources:

1. Gupta, Mohak et al. "Aspirin Use Prevalence for Cardiovascular Disease Prevention Among U.S. Adults From 2012 to 2021." Annals of Internal Medicine (2024). https://www.acpjournals.org/doi/10.7326/M24-0427

2. American College of Cardiology. "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease." Journal of the American College of Cardiology(2019). https://www.jacc.org/doi/full/10.1016/j.jacc.2019.03.010

3. EurekAlert! "Survey shows aspirin use remains high among older adults, despite risks." American College of Physicians, June 24, 2024. 

4. GreenMedInfo.com. "Aspirin: 100 Research Articles." Accessed June 25, 2024. https://greenmedinfo.com/toxic-ingredient/aspirin

5. Yeomans, Neville D et al. "Systematic review: ulcers from aspirin and other nonsteroidal anti-inflammatory drugs--evidence-based recommendations for primary care." Alimentary Pharmacology & Therapeutics(2009). https://pubmed.ncbi.nlm.nih.gov/19788350/

6. Rich, Jonathan D et al. "Greater risk of death and MI in patients with prior aspirin use: results from a large cohort of 52,279 patients with acute coronary syndromes." Journal of the American College of Cardiology(2010). https://pubmed.ncbi.nlm.nih.gov/20946994/

7. Chen, Guang-Di et al. "Salicylate-induced cochlear impairments, cortical hyperactivity and re-tuning, and tinnitus." Hearing Research(2010). https://pubmed.ncbi.nlm.nih.gov/20214971/

8. Chen, Ting et al. "Aspirin for primary prevention of cardiovascular events in patients with chronic kidney disease: A systematic review and meta-analysis." Current Vascular Pharmacology (2023). https://pubmed.ncbi.nlm.nih.gov/37259222/

9. Welin, Lennart et al. "Aspirin increases mortality in diabetic patients without cardiovascular disease: a Swedish record linkage study." Pharmacoepidemiology and Drug Safety (2009). https://pubmed.ncbi.nlm.nih.gov/19672841/